Press Release: The Pharmaceutical Compliance Forum's Eighteenth Pharmaceutical and Medical Device Compliance Congress Features Compliance and Ethics Consideration in R&D
  • Sponsored by the Pharmaceutical Compliance Forum
  • November 6 - 8, 2017
  • Onsite at the Mandarin Oriental, Washington, DC
  • Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com
EARLY BIRD REGISTRATION
-- SAVE UP TO $400 --
Register by Friday, September 22, 2017 and save up to $400.
Click here to register.

FEATURING COMPLIANCE AND ETHICS CONSIDERATIONS IN R&D BY

David Cromley, JD
Associate Vice President, Merck, Philadelphia, PA

Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ

Michelle Shwery, MSc, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Former Interim Chief Compliance Officer, Misonix, Inc., West Chester, PA

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 9, 2017: The Pharmaceutical Compliance Forum's Eighteenth Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 6 - 8, 2017 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).

KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD

Charles Cain, Esq.
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC

Susan Dentzer
President and Chief Executive Officer, NEHI (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC

Colin M. Huntley, JD
Assistant Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC

Pablo Quiñones, JD
Chief, Strategy, Policy and Training Unit, Fraud Section, Criminal Division, US Department of Justice, Former Assistant United States Attorney in the Criminal Division, US Attorney’s Office for the Southern District of New York, Washington, DC

Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

James Sheehan, JD
Chief, Charities Bureau at Attorney General of New York, Former Chief Integrity Officer, Executive Deputy Commissioner, City of New York Human Resources Administration, Former, NY Medicaid Inspector General, Former Associate United States Attorney, US Attorney's Office for the Eastern District of Pennsylvania, New York, NY

Darryl Wegner, JD
Unit Chief, International Corruption Unit, FBI, Washington, DC

CO CHAIRS

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Chicago, IL

Matthew D'Ambrosio, JD, MBA
Senior Vice President, Chief Compliance and Ethics Officer, Sunovion Pharmaceuticals Inc., Chair, Pharmaceutical Compliance Forum, Marlborough, MA

Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ

Jeffrey Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., New York, NY

Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD

Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi, US, Bridgewater, NJ

FEATURED FACULTY

Thomas W. Beimers, Esq.
Partner, Hogan Lovells, Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Department of Health and Human Services, Minneapolis, MN

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC

David Cromley, JD
Associate Vice President, Merck, Philadelphia, PA

Michelle Drozd, ScM
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC

Jacob T. Elberg
Chief, Health Care and Government Fraud Unit, United States Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY

Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells LLP, Former Executive Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Gejaa T. Gobena, JD
Partner, Hogan Lovells, Former Deputy Chief, Fraud Section, Criminal Division, Former Trial Attorney, Civil Division, Fraud Section, US Department of Justice, Washington, DC

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC

Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC

Jason Mehta, JD
Assistant US Attorney, United States Attorney's Office Middle District of Florida, US Department of Justice, Jacksonville, FL

Michael A. Morse, JD
Partner, Pietragallo, Gordon, Alfano, Bosick & Raspanti, Former Assistant District Attorney, Philadelphia District Attorney's Office, Philadelphia PA

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC

Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ

Gregg Shapiro, JD
Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA

Michelle Shwery, MSc, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN

Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA, Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Former Interim Chief Compliance Officer, Misonix, Inc., West Chester, PA

2017-2018 GLOBAL PHARMA COMPLIANCE CONGRESSES

ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.International PharmaCongress.com
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.Asian PharmaCongress.com
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com


INDIAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by International Society of Healthcare Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Spring 2018
Mumbai, India
Coming Soon

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES


2007 - Brussels



2008 - Paris



2009 - Rome



2010 - Berlin



2011 - Istanbul



2011 - Singapore



2012 - Budapest



2012 - Shanghai



2012 - São Paulo



2013 - Madrid



2013 Kuala Lumpur



2014 - Dubai



2014 - Mexico City



2015 - Manila



2016 - Warsaw



2017 - Lisbon


SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.

GRANTORS:
PLATINUM


SILVER




BRONZE




























MEDIA PARTNERS:






CONTINUING EDUCATION CREDITS:
Accounting Professionals: Pending approval for NASBA CPE credits.

Attorney Credits: Pending Approval for PA MCLE credits.

Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.

Click here for more information.

PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction



LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





WEBCAST INTERFACE SAMPLE

Click here for a sample stream

STAY CONNECTED




Tweet using #PharmaCongress

PHARMA CONGRESS IS


CONGRESS REGISTRATION
For Congress registration information, visit http://pharmacongress.com/registration/, email registration@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information visit http://pharmacongress.com/promotional-opportunities/, or contact Justin Sorensen, Exhibit Manager, 206-452-0609 phone, 206-319-5303 fax, exhibits@hcconferences.com.